Skip to main content

Table 1 Baseline characteristics of RA patients and the healthy controls

From: Sleep quality in Chinese patients with rheumatoid arthritis: contributing factors and effects on health-related quality of life

Variables

Cases (n = 131)

Controls (n = 104)

p

Gender, female, N (%)

112 (85.5)

88 (84.6)

0.79

BMI (kg/m2), Mean ± SD

22.5 ± 3.12

22.84 ± 2.81

0.432

Age (years), Mean ± SD

54.5 ± 11.5

54.77 ± 11.20

0.851

Monthly income (yuan), N (%)

  

0.973

 <1000

67 (51.1)

55 (52.9)

 

 1000-3000

47 (35.9)

35 (33.7)

 

 3000-5000

13 (9.9)

10 (9.6)

 

 >5000

4 (3.1)

4 (3.8)

 

Marital status, N (%)

  

0.411

 Single

7 (5.3)

11 (10.6)

 

 Married

118 (90.1)

90 (86.5)

 

 Divorced

1 (0.8)

1 (1.0)

 

 Widowed

5 (3.8)

2 (1.9)

 

Education, N (%)

  

0.571

 ≤9 years

93 (71.0)

70 (76.9)

 

 >9 years

38 (29.0)

34 (23.1)

 

Occupation, N (%)

  

0.757

 Employed

102 (77.9)

80 (80.8)

 

 Unemployed

29 (22.1)

24 (19.2)

 

Alcohol use, yes, N (%)

24 (18.3)

19 (18.3)

1.000

Smoking use, yes, N (%)

10 (7.6)

10 (9.6)

0.642

Disease duration (years), Mean ± SD

8.7 ± 9.1

  

Family history, yes, N (%)

10 (7.6)

  

Medications use, N (%)

   

 NSAIDs

692 (52.7)

  

 Synthetic DMARDs

129 (98.5)

  

 Biologic DMARDs

11 (8.4)

  

 Glucocorticoid

62 (47.3)

  

ESR (mm/h), Mean ± SD

28.47 ± 27. 64

  

CRP (mg/L), Mean ± SD

16.61 ± 24.51

  

RF positive, N (%)

102 (77.9)

  

anti-CCP positive, N (%)

91 (69.5)

  

DAS28, Mean ± SD

3.96 ± 1.44

  

HAQ-DI, Mean ± SD

0.50 ± 0.61

  

Total pain (VAS), Mean ± SD

4.32 ± 2.76

  

Nocturnal pain (VAS), Mean ± SD

3.95 ± 3.22

  

HADS-A, Mean ± SD

9.12 ± 2.79

  

HADS-D, Mean ± SD

8.74 ± 2.46

  
  1. Data are means ± SD for continuous variables, or percentages for categorical variables
  2. p values were obtained with the chi-square test for categorical variables and the two-tailed t test for continuous variables
  3. BMI Body Mass Index, NSAID Nonsteroidal anti-Inflammatory Drugs, DMARD Disease-Modifying Antirheumatic Drugs, ESR Erythrocyte Sedimentation Rate, CRP C-reactive Protein, RF Rheumatoid Factor, anti-CCP anti-cyclic citrullinated peptide, DAS28 Disease Activity Score in 28 Joints, HAQ-DI Health Assessment Questionnaire-Disability Index, VAS Visual Analog Scale, HADS Hospital Anxiety and Depression Scale, SF-36 the Medical Outcomes Study Short Form 36, PCS Physical Components Summary, MCS Mental Components Summary, PSQI Pittsburgh Sleep Quality Index